Physician

Jennifer Shih Winn, M.D.

According to 2025 Medicare claims, Jennifer Winn, M.D. (NPI: 1063671766) practices hematopoietic cell transplantation and cellular therapy in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN, INC (NPI: 1417430166; TIN: 831002191) and primary practice location at 18925-1262.

Winn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 208 traditional Medicare patients, billed 759 HCPCS/CPT codes, and received $58,677 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 961 prescription claims across 218 beneficiaries totaling $3,620,547 in drug costs, led by Ibrance (Palbociclib). DME data shows 39 claims. Open Payments data shows 5 records totaling $162. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $36,892 and ending at $58,677. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $410,309 to $3,620,547. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	208	427	$36,892
2016	208	392	$35,605
2017	224	455	$39,609
2018	259	517	$47,206
2019	260	503	$45,138
2020	192	361	$32,530
2021	230	572	$48,568
2022	229	648	$58,809
2023	173	433	$37,152
2024	208	759	$58,677

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	160	701	$410,309
2016	179	696	$358,874
2017	182	719	$474,184
2018	212	808	$704,624
2019	193	832	$1,785,038
2020	176	752	$1,179,067
2021	167	600	$1,117,589
2022	205	741	$1,751,005
2023	180	740	$1,878,691
2024	218	961	$3,620,547

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	27	$22,280
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	50	$9,591
2019	N/R	29	$3,300
2020	N/R	31	$1,885
2021	N/R	29	$2,012
2022	13	16	$1,605
2023	N/R	N/R	N/R
2024	N/R	39	$2,334

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	50	50	$141
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	162	342	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	28	29	$65
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	78	266	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	135	3,836	$2,138,031
Orserdu	Elacestrant Hcl	12	360	$286,774
Kisqali	Ribociclib Succinate	18	504	$242,200
Truqap	Capivasertib	12	392	$212,943
Anastrozole	Anastrozole	281	22,885	$7,299

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	13	$1,577
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$512
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$245

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$162	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jennifer Shih Winn, M.D.?

Tedicare shows public-source Medicare data for Jennifer Shih Winn, M.D. (NPI 1063671766), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jennifer Shih Winn, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jennifer Shih Winn, M.D.?

Jennifer Shih Winn, M.D. is linked to TEMPLE FACULTY PRACTICE PLAN, INC (billing NPI 1417430166) in the available physician profile data.

Does Jennifer Shih Winn, M.D. have Open Payments data?

Jennifer Shih Winn, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.